Hepatotoxicity related to Anakinra has been reported in pediatric rheumatology patients. LFT elevations have been reported with IL-1 inhibition, even after excluding LFTs from the inflamm Dx, other drugs, MAS, etc. Here are 3 case reports. https://t.co/6ZxIcHbUEd https://t.co/Cx0kbn7JU2
Links:
Anakinra and hepatotoxicity in pediatric rheumatology: a case series
https://bit.ly/3ZVDSKM
Oct-15-2023
